Clinomics Inc. (KOSDAQ:352770)
South Korea
· Delayed Price · Currency is KRW 490.00
+1.00 (0.20%)
At close: Apr 1, 2025, 3:30 PM KST
Clinomics Market Cap
Clinomics has a market cap or net worth of 18.84 billion as of April 1, 2025. Its market cap has decreased by -75.40% in one year.
Market Cap
18.84B
Enterprise Value
47.72B
Revenue
8.25B
Ranking
n/a
PE Ratio
n/a
Stock Price
490.00
Market Cap Chart
Since December 4, 2020, Clinomics's market cap has decreased from 250.90B to 18.84B, a decrease of -92.49%. That is a compound annual growth rate of -45.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 18.80B | -5.96% |
| Dec 30, 2024 | 19.99B | -75.62% |
| Dec 28, 2023 | 82.01B | -6.89% |
| Dec 29, 2022 | 88.08B | -48.30% |
| Dec 30, 2021 | 170.35B | -24.47% |
| Dec 30, 2020 | 225.54B | -10.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 380.67T |
| SK hynix | 131.40T |
| LG Energy Solution | 78.27T |
| Samsung Biologics | 72.17T |
| Hyundai Motor Company | 43.02T |
| Kia Corporation | 36.34T |
| Celltrion | 36.29T |
| KB Financial Group | 29.30T |